Status:
COMPLETED
Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients
Lead Sponsor:
First Affiliated Hospital of Chongqing Medical University
Conditions:
Pemphigus Vulgaris
Eligibility:
All Genders
Up to 80 years
Brief Summary
The objective of this retrospective study was to investigate the factors influencing in-hospital relapse during acute episodes of pemphigus, an autoimmune blistering disease characterized by self-anti...
Detailed Description
This retrospective study conducted in China between January 2014 and December 2020 aimed to comprehensively examine factors influencing in-hospital relapse during acute episodes of pemphigus, an autoi...
Eligibility Criteria
Inclusion
- inpatients.
- Pathologic diagnosis of pemphigus.
Exclusion
- Patients hospitalized for cyclophosphamide shock therapy only.
- Patients who did not recover and were discharged due to personal reasons.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06167408
Start Date
January 1 2022
End Date
June 1 2022
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated hospital of Chongqing Medical University
Chongqing, Yuzhong District, China, 400000